Bacteremia in childhood cancer

被引:22
作者
Celkan, T [1 ]
Ozkan, A [1 ]
Apak, H [1 ]
Diren, S [1 ]
Can, G [1 ]
Yuksel, L [1 ]
Yildiz, I [1 ]
机构
[1] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat Hematol Oncol, Istanbul, Turkey
关键词
D O I
10.1093/tropej/48.6.373
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Infection-related mortality affects the overall survival rates of children who are receiving treatment for cancer. The leading cause of mortality is bacteremia and sepsis related to it in febrile neutropenic patients. All positive blood cultures of febrile neutropenic patients treated in the Department of Pediatric Hematology-Oncology, Cerrahpasa Medical School, between January 1995 and January 2001 were reviewed. Cultures grew 159 micro-organisms, 95 (60 per cent) of which were Gram-positive bacteria, 56 (35 per cent) were Gram-negative bacteria and eight (5 per cent) were fungi. Coagulase-negative staphylococci (63, 40 per cent) and S. aureus (8, 5 per cent) were the most frequent Gram-positive pathogens. Klebsiella, E. coli, Enterobacter and Pseudomonas infections were the primary Gram-negative pathogens. Twenty cases were lost because of sepsis: in 11 cases (55 per cent) Gram-negative bacteria, in eight cases (40 per cent) Gram-positive bacteria, and in only one case a fungus were the causative organisms. Although vancomycin was not included in the first-line treatment, the mortality rate of Gram-positive bacteremia was 8 per cent. In Gram-negative bacteremia it was 20 per cent. Gram-negative pathogens, which were resistant to multiple antibiotics, caused the mortality. Drug resistance and mortality due to micro-organisms must be taken into consideration while febrile neutropenia protocols are prepared.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 19 条
  • [1] Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service
    Aledo, A
    Heller, G
    Ren, L
    Gardner, S
    Dunkel, I
    McKay, SW
    Flombaum, C
    Brown, AE
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (03) : 215 - 221
  • [2] CELKAN T, 2001, AUSTRAL ASIAN J CANC, V1, P20
  • [3] CELKAN T, 1999, MED PEDIATR ONCOL, V33, P319
  • [4] Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer -: Retrospective analysis of 245 episodes
    Chatzinikolaou, I
    Abi-Said, D
    Bodey, GP
    Rolston, KVI
    Tarrand, JJ
    Samonis, G
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) : 501 - 509
  • [5] PROSPECTIVE MULTICENTRIC STUDY OF THE ETIOLOGY OF 1051 BACTEREMIC EPISODES IN 782 CANCER-PATIENTS
    COULLIOUD, D
    VANDERAUWERA, P
    VIOT, M
    LASSET, C
    [J]. SUPPORTIVE CARE IN CANCER, 1993, 1 (01) : 34 - 46
  • [6] Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia
    González-Barca, E
    Fernández-Sevilla, A
    Carratalá, J
    Salar, A
    Peris, J
    Grañena, A
    Gudiol, F
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (08) : 539 - 544
  • [7] A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies
    Hann, I
    Viscoli, C
    Paesmans, M
    Gaya, H
    Glauser, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (03) : 580 - 588
  • [8] 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
    Hughes, WT
    Armstrong, D
    Bodey, GP
    Brown, AE
    Edwards, JE
    Feld, R
    Pizzo, P
    Rolston, KVI
    Shenep, JL
    Young, LS
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) : 551 - 573
  • [9] JORGENSEN JH, 1997, M2A6 NCCLS
  • [10] Nosocomial bloodstream infections: Organisms, risk factors, and implications
    Karchmer, AW
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 : S139 - S143